The expression of wildtype Parkin in a neuroblastoma cell line was shown to activate NF-κB through IKK, using luciferase reporter and gel shift assays, while expression of Parkin harboring pathogenic mutations associated with PD exhibited reduced capacity to activate NF-κB (119). This evidence concerns the gene NFKB1 and neuroblastoma.